Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Rothe
Observed names:
M Rothe,
M. Rothe,
Rothe, Michael
Institutions:
Medizinische Hochschule Hannover,
Research Center for Translational Regenerative Medicine
Observed institutions:
Max Delbrück Center,
Medizinische Hochschule Hannover,
Berlin Institute of Health at Charité - Universitätsmedizin Berlin,
Center for Experimental and Clinical Infection Research,
Research Center for Translational Regenerative Medicine,
Charité - Universitätsmedizin Berlin
show all 6
ORCID:
0000-0002-6813-4705
Observed ORCID:
0000-0002-6813-4705
OpenAlex ID:
A5102908575
Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity
2014
·
Christian Jörg Braun
, Kaan Boztug
, et al.
·
Science Translational Medicine
·
560
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
2017
·
Thomas Kammertoens
, Christian Friese
, et al.
·
Nature
·
269
Bromo- and Extraterminal Domain Chromatin Regulators Serve as Cofactors for Murine Leukemia Virus Integration
2013
·
Saumya Shree Gupta
, Tobias Maetzig
, et al.
·
Journal of Virology
·
139
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
2014
·
Olivier Negre
, Cynthia Bartholomae
, et al.
·
Current Gene Therapy
·
125
Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-Enhancer Urokinase-Type Plasminogen Activator Mice
2009
·
Dhivya Haridass
, Qinggong Yuan
, et al.
·
American Journal Of Pathology
·
113
PDF
Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
2014
·
Michael Rothe
, Ute Modlich
, et al.
·
Current Gene Therapy
·
109
Massive Clonal Selection and Transiently Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by Lentiviral RGB-Barcode Technology
2016
·
Anton Selich
, Jannik Daudert
, et al.
·
Stem Cells Translational Medicine
·
96
PDF
DNA methylation changes during long-term in vitro cell culture are caused by epigenetic drift
2021
·
Julia Franzen
, Theodoros Georgomanolis
, et al.
·
Communications Biology
·
87
PDF
Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor
2014
·
Orit Wolstein
, Maureen Boyd
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
73
PDF
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy
2020
·
Christian Brendel
, Olivier Negre
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
72
PDF
Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
2015
·
Maria Dahl
, Alexander Doyle
, et al.
·
Molecular Therapy
·
67
Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
2020
·
Laura Garcia-Perez
, Marja van Eggermond
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
56
PDF
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency
2016
·
Divya Punwani
, Misako Kawahara
, et al.
·
Human Gene Therapy
·
55
Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning
2021
·
Adrian Schwarzer
, Steven R. Talbot
, et al.
·
Molecular Therapy
·
50
PDF
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
2018
·
Valentina Poletti
, Sabine Charrier
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
50
PDF
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
2017
·
Ju Huang
, Aneal Khan
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
49
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
2019
·
Anton Selich
, Katharina Zimmermann
, et al.
·
Stem Cell Research & Therapy
·
46
PDF
Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
2017
·
Luca Biasco
, Michael Rothe
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
44
PDF
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease
2018
·
Christian Brendel
, Michael Rothe
, et al.
·
Human Gene Therapy Clinical Development
·
36
Gene therapy cures the anemia and lethal bone marrow failure in a mouse model of RPS19-deficient Diamond-Blackfan anemia
2014
·
P. Jaako
, S. Debnath
, et al.
·
Haematologica
·
36
PDF
Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors
2011
·
Razvan Iacob
, Urda Rüdrich
, et al.
·
Stem Cell Research
·
33
PDF
Safety of Gene Therapy: New Insights to a Puzzling Case
2014
·
Michael Rothe
, Axel Schambach
, et al.
·
Current Gene Therapy
·
32
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials
2024
·
Paula Río
, Josune Zubicaray
, et al.
·
The Lancet
·
31
CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo
2018
·
Swantje I. Hammerschmidt
, Kathrin Werth
, et al.
·
Frontiers in Immunology
·
31
PDF
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues
2020
·
Andreas Winkel
, Yarúa Jaimes
, et al.
·
Cytotherapy
·
30
Show more works
View as search
Works count:
111
Citation count:
2,894
H-index:
26
I10-index:
48
Year
Topic
Type